Cost-effectiveness of population-wide genomic screening for Lynch syndrome in the United States
- 25 February 2022
- journal article
- research article
- Published by Elsevier in Genetics in Medicine
- Vol. 24 (5) , 1017-1026
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Uptake of Genetic Testing by Relatives of Lynch Syndrome Probands: A Systematic ReviewClinical Gastroenterology and Hepatology, 2013
- Identification of Lynch Syndrome Among Patients With Colorectal CancerJAMA, 2012
- Cancer Risks Associated With Germline Mutations in MLH1, MSH2, and MSH6 Genes in Lynch SyndromeJAMA, 2011
- Health Benefits and Cost-Effectiveness of Primary Genetic Screening for Lynch Syndrome in the General PopulationCancer Prevention Research, 2011
- Evaluating Lynch syndrome in very early onset colorectal cancer probands without apparent polyposisFamilial Cancer, 2009
- Cancer risk in a cohort of subjects carrying a single mismatch repair gene mutationFamilial Cancer, 2009
- Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramificationsClinical Genetics, 2009
- EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndromeGenetics in Medicine, 2009
- Feasibility of Screening for Lynch Syndrome Among Patients With Colorectal CancerJournal of Clinical Oncology, 2008
- Phenotype Comparison of MLH1 and MSH2 Mutation Carriers in a Cohort of 1,914 Individuals Undergoing Clinical Genetic Testing in the United StatesCancer Epidemiology, Biomarkers & Prevention, 2008